<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37665505</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-6014</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of epidemiology and global health</Title><ISOAbbreviation>J Epidemiol Glob Health</ISOAbbreviation></Journal><ArticleTitle>Post COVID-19 Symptoms Among Infected Vaccinated Individuals: A Cross-Sectional Study in Saudi Arabia.</ArticleTitle><Pagination><StartPage>740</StartPage><EndPage>750</EndPage><MedlinePgn>740-750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s44197-023-00146-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Multiple studies investigated the endurance and occurrence of symptoms three months&#xa0;after SARS-CoV-2 infection. This study examines the possible&#xa0;effects of COVID-19 vaccination on the persistence of post-recovery symptoms.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A cross-sectional survey was conducted in Saudi Arabia to evaluate 14 prevalent long COVID-19 symptoms among vaccinated individuals. Patients self-reported their acute COVID-19 experience, demographic information, chronic conditions, vaccine history, and persistent symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 484 patients, four respondents were excluded from the study as they had not received the vaccine, and 111 (23.1%) were vaccinated but did not get infected and were also excluded. The remaining 369 (76.9%) reported COVID-19 and a vaccination and thus they were included in the study. The occurrence of post-COVID-19 symptoms was reported&#xa0;in 59 (16.1%) for&#x2009;&#x2264;&#x2009;3&#xa0;months, 202 (54.8%) experienced persistent symptoms 3-6&#xa0;months, and 108 (29.1%) reported symptoms lasting&#x2009;&gt;&#x2009;6&#xa0;months. In relation to age group, persistent symptoms 3-6&#xa0;months after recovery was more common in those&#x2009;&gt;&#x2009;50&#xa0;years and symptoms lasting&#x2009;&gt;&#x2009;6&#xa0;months were more common in 30-50&#xa0;years of age (p&#x2009;&lt;&#x2009;0.001). Persistence of symptoms for&#x2009;&#x2009;3-6&#xa0;months was more common in those who were infected prior to vaccination compared to those who were infected after vaccination (P&#x2009;&lt;&#x2009;0.001). Of the included patients, 323 (87.5%) rated their health as good, 41 (11.1%) considered it fair, and 5 (1.4%) described their well-being as poor or terrible.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study provides information&#xa0;of persistent symptoms in vaccinated individuals who had recovered from COVID-19 and highlights the need for targeted interventions to alleviate post-COVID-19 symptoms. The study is limited by its reliance on self-reported data and potential selection bias. Future research is needed to understand the mechanisms underlying persistent symptoms in vaccinated individuals and to identify effective interventions for long COVID.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adly</LastName><ForeName>Heba M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Community Medicine and Pilgrims Healthcare Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Saleh A K</ForeName><Initials>SAK</Initials><AffiliationInfo><Affiliation>Biochemisty Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oncology Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garout</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Community Medicine and Pilgrims Healthcare Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulkhaliq</LastName><ForeName>Altaf A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Biochemisty Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khafagy</LastName><ForeName>Abdullah A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Community Medicine and Pilgrims Healthcare Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saati</LastName><ForeName>Abdullah A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Community Medicine and Pilgrims Healthcare Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlJahdali</LastName><ForeName>Imad A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Community Medicine and Pilgrims Healthcare Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alandiyjany</LastName><ForeName>Maher N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quality and Development Affair, Batterjee Medical College, 21442, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Tawfiq</LastName><ForeName>Jaffar A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-5752-2235</Identifier><AffiliationInfo><Affiliation>Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia. jaffar.tawfiq@jhah.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. jaffar.tawfiq@jhah.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jaffar.tawfiq@jhah.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IFP22UQU4240001DSR010</GrantID><Agency>Ministry of Education - Kingdom of Saudi Arabi</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Epidemiol Glob Health</MedlineTA><NlmUniqueID>101592084</NlmUniqueID><ISSNLinking>2210-6006</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Post recovery</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Saudi Arabia</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>None of the authors has any conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37665505</ArticleId><ArticleId IdType="pmc">PMC10686930</ArticleId><ArticleId IdType="doi">10.1007/s44197-023-00146-9</ArticleId><ArticleId IdType="pii">10.1007/s44197-023-00146-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727&#x2013;733. doi: 10.1056/nejmoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. People, population and community n.d. https://www.ons.gov.uk/peoplepopulationandcommunity (Accessed June 2, 2023).</Citation></Reference><Reference><Citation>Oxford Martin School. Coronavirus (COVID-19) Vaccinations - Our World in Data n.d. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL (Accessed January 13, 2023).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Long COVID or Post-COVID Conditions n.d. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (Accessed June 2, 2023).</Citation></Reference><Reference><Citation>Tran V-T, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2:e000229. doi: 10.1136/BMJMED-2022-000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJMED-2022-000229</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Riveros C, Clepier BCDS, Desvarieux M, Collet C, Yordanov Y, et al. Development and validation of the long coronavirus disease (COVID) symptom and impact tools: a set of patient-reported instruments constructed from patients&#x2019; lived experience. Clin Infect Dis. 2022;74:278&#x2013;87. doi: 10.1093/CID/CIAB352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAB352</ArticleId><ArticleId IdType="pmc">PMC8135558</ArticleId><ArticleId IdType="pubmed">33912905</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/S41591-021-01292-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01292-Y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Polish Arch Intern Med. 2023 doi: 10.20452/pamw.16402.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Gawad M, Zaghloul MS, Abd-elsalam S, Hashem M, Lashen SA, Mahros AM, et al. Post-COVID-19 syndrome clinical manifestations: a systematic review. Antiinflamm Antiallergy Agents Med Chem. 2022;21:115&#x2013;120. doi: 10.2174/1871523021666220328115818.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871523021666220328115818</ArticleId><ArticleId IdType="pubmed">35346011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud MH, Alghamdi FA, Alghamdi GA, Alkhotani LA, Alrehaili MA, El-Deeb DK. Study of Post-COVID-19 syndrome in Saudi Arabia. Cureus. 2021 doi: 10.7759/CUREUS.17787.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/CUREUS.17787</ArticleId><ArticleId IdType="pmc">PMC8495763</ArticleId><ArticleId IdType="pubmed">34659998</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID) 2022. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (Accessed June 2, 2023).</Citation></Reference><Reference><Citation>Kobayashi M, Miyamoto A, Watanabe T, Sawa K, Sato K, Yamada K, et al. COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: an analysis in the first specialized hospital for COVID-19 in Japan. Respir Investig. 2023;61:230&#x2013;239. doi: 10.1016/J.RESINV.2022.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RESINV.2022.12.011</ArticleId><ArticleId IdType="pmc">PMC9892338</ArticleId><ArticleId IdType="pubmed">36774816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinands JM, Rao S, Dixon BE, Mitchell PK, Desilva MB, Irving SA, et al. Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. BMJ. 2022 doi: 10.1136/BMJ-2022-072141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-072141</ArticleId><ArticleId IdType="pmc">PMC9527398</ArticleId><ArticleId IdType="pubmed">36191948</ArticleId></ArticleIdList></Reference><Reference><Citation>AlBahrani S, AlBarrak A, Al-Musawi T, AlGubaisi NA, Almalki M, Hakami FH, et al. COVID-19 vaccine had a significant positive impact on patients with SARS-COV-2 during the third (Omicron) wave in Saudi Arabia. J Infect Public Health. 2022;15:1169&#x2013;1174. doi: 10.1016/j.jiph.2022.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.09.005</ArticleId><ArticleId IdType="pmc">PMC9490953</ArticleId><ArticleId IdType="pubmed">36215800</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/BMJMED-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJMED-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022 doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>AlBahrani S, AlBarrak A, AlGubaisi N, Alkurdi H, Alburaiki D, AlGhamdi A, et al. Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers. J Infect Public Health. 2023;16:1276&#x2013;1280. doi: 10.1016/j.jiph.2023.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.05.037</ArticleId><ArticleId IdType="pmc">PMC10240906</ArticleId><ArticleId IdType="pubmed">37315430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, Sheikh AAE, Khan AM, Khalid SN, Khan J, Nasrullah A, et al. COVID-19 vaccine and long COVID: a scoping review. Life. 2022 doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr NM, Plumb ID, Harland KK, Pilishvili T, Fleming-Dutra KE, Krishnadasan A, et al. Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study. BMJ Open. 2023 doi: 10.1136/bmjopen-2022-063141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063141</ArticleId><ArticleId IdType="pmc">PMC9895915</ArticleId><ArticleId IdType="pubmed">36731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6:e2251360. doi: 10.1001/jamanetworkopen.2022.51360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/S41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population. MedRxiv. 2022 doi: 10.1101/2022.02.27.22271328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.27.22271328</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA - J Am Med Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O&#x2019;Mahoney LL, Stephenson TJ, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84:158&#x2013;170. doi: 10.1016/J.JINF.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JINF.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76:405&#x2013;7. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:1&#x2013;10. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022 doi: 10.1038/S41467-022-29521-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-022-29521-Z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2022 doi: 10.1016/J.ECLINM.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Monod M, Blenkinsop A, Xi X, Hebert D, Bershan S, Tietze S, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science. 2021;371:6536. doi: 10.1126/SCIENCE.ABE8372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABE8372</ArticleId><ArticleId IdType="pmc">PMC8101272</ArticleId><ArticleId IdType="pubmed">33531384</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang IW, Vieira VM, Shearer E. Effect of socioeconomic factors during the early COVID-19 pandemic: a spatial analysis. BMC Public Health. 2022 doi: 10.1186/s12889-022-13618-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13618-7</ArticleId><ArticleId IdType="pmc">PMC9205762</ArticleId><ArticleId IdType="pubmed">35715743</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher AN, Ryan MK. Gender inequalities during COVID-19. Gr Process Intergr Relations. 2021;24:237&#x2013;245. doi: 10.1177/1368430220984248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1368430220984248</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerre A, Doblhammer G. The influence of gender on COVID-19 infections and mortality in Germany: Insights from age- and gender-specific modeling of contact rates, infections, and deaths in the early phase of the pandemic. PLoS One. 2022;17:e0268119. doi: 10.1371/journal.pone.0268119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268119</ArticleId><ArticleId IdType="pmc">PMC9075634</ArticleId><ArticleId IdType="pubmed">35522614</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentr&#xe9; F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27:1041.e1&#x2013;1041.e4. doi: 10.1016/j.cmi.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir MM, Shabana HA, Rasheed Z, Alkhamiss AS, Khodeir M, Alkhowailed MS, et al. COVID-19: post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One. 2021;16:e0260259. doi: 10.1371/JOURNAL.PONE.0260259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar MA, Martins RS, Dhillon RA, Tharwani A, Irfan O, Suriya QF, et al. Residual symptoms and the quality of life in individuals recovered from COVID-19 infection: a survey from Pakistan. Ann Med Surg. 2022 doi: 10.1016/J.AMSU.2022.103361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AMSU.2022.103361</ArticleId><ArticleId IdType="pmc">PMC8832846</ArticleId><ArticleId IdType="pubmed">35186286</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabali MA, Alsabban AS, Bahakeem LM, Zwawy MA, Bagasi AT, Bagasi HT, et al. Persistent symptoms post-COVID-19: an observational study at King Abdulaziz Medical City, Jeddah. Saudi Arabia. Cureus. 2022 doi: 10.7759/cureus.24343.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24343</ArticleId><ArticleId IdType="pmc">PMC9123896</ArticleId><ArticleId IdType="pubmed">35607525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;6. doi: 10.1016/J.JINF.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JINF.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Garout MA, Saleh SAK, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, et al. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection. 2022;50:1431&#x2013;1439. doi: 10.1007/s15010-022-01788-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01788-w</ArticleId><ArticleId IdType="pmc">PMC8924350</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst JD, Mathiasen V, Hansen K, S&#xf8;gaard O, &#xd8;stergaard L, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021 doi: 10.1093/ofid/ofab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Regunath H, Goldstein NM, Guntur VP. Long COVID: where are we in 2023? Mo Med. 2023;120:102&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10121126</ArticleId><ArticleId IdType="pubmed">37091941</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman MS, Harun MGD, Sumon SA, Mohona TM, Abdullah SAHM, Khan MNH, et al. Hospitalization and mortality by vaccination status among COVID-19 patients aged &#x2265; 25 years in Bangladesh: results from a multicenter cross-sectional study. Vaccines. 2022 doi: 10.3390/vaccines10121987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10121987</ArticleId><ArticleId IdType="pmc">PMC9786706</ArticleId><ArticleId IdType="pubmed">36560397</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang NYL, Pang ASR, Chow VT, Wang DY. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Mil Med Res. 2021 doi: 10.1186/s40779-021-00342-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-021-00342-3</ArticleId><ArticleId IdType="pmc">PMC8405719</ArticleId><ArticleId IdType="pubmed">34465396</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar SMF, Al Mahtab M, Khan S. Cellular and molecular mechanisms of pathogenic and protective immune responses to SARS-CoV-2 and implications of COVID-19 vaccines. Vaccines. 2023 doi: 10.3390/vaccines11030615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030615</ArticleId><ArticleId IdType="pmc">PMC10053541</ArticleId><ArticleId IdType="pubmed">36992199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023 doi: 10.7554/eLife.86014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86014</ArticleId><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023 doi: 10.7554/elife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, Jimenez M, Lim PH, Orban ZS, et al. Multidisciplinary center care for long covid syndrome&#x2014;a retrospective cohort study. Am J Med. 2023 doi: 10.1016/j.amjmed.2023.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.05.002</ArticleId><ArticleId IdType="pmc">PMC10200714</ArticleId><ArticleId IdType="pubmed">37220832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>